$OPI
OFFICE PROPERTIES INCOME TRUST Stock $opi

$opi Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000145677224000035 Filed on May 01, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$123.7M	$139.4M
YoY Change	-7.69%	5.3%
Cost Of Revenue	$41.88M	$43.04M
YoY Change	-1.54%	3.98%
Gross Profit	$81.81M	$96.40M
YoY Change	-10.56%	5.9%
Gross Profit Margin	66.14%	69.14%
Selling, General & Admin	$11.05M	$13.80M
YoY Change	-4.12%	4.63%
% of Gross Profit	13.51%	14.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$47.77M	$29.70M
YoY Change	-3.46%	19.05%
% of Gross Profit	58.39%	30.81%
Operating Expenses	$61.44M	$64.14M
YoY Change	-2.67%	-1.14%
Operating Profit	$20.36M	$32.26M
YoY Change	-28.13%	23.35%
Interest Expense	$38.35M	$35.48M
YoY Change	44.58%	40.6%
% of Operating Profit	188.31%	109.96%
Other Income/Expense, Net
YoY Change
Pretax Income	$76.24M	-$4.898M
YoY Change	-772.35%	-1271.77%
Income Tax	-$107.0K	$56.00K
% Of Pretax Income	-0.14%
Net Earnings	$76.17M	-$5.184M
YoY Change	-722.21%	1062.33%
Net Earnings / Revenue	61.58%	-3.72%
Basic Earnings Per Share	$1.56	-$0.11
Diluted Earnings Per Share	$1.56	-$0.11
COMMON SHARES
Basic Shares Outstanding	48.75M shares	48.75M shares
Diluted Shares Outstanding	48.65M shares	48.47M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.50M	$23.51M
YoY Change	-46.46%	0.72%
Cash & Equivalents	$13.50M	$23.51M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$140.5M	$137.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$154.0M	$161.0M
YoY Change	13.4%	23.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.397B	$3.645B
YoY Change	-9.39%	-2.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$17.72M	$17.90M
YoY Change	-52.58%	-51.04%
Other Assets	$222.2M	$118.3M
YoY Change	133.8%	52.89%
Total Long-Term Assets	$3.646B	$3.797B
YoY Change	-6.32%	-2.06%
TOTAL ASSETS
Total Short-Term Assets	$154.0M	$161.0M
Total Long-Term Assets	$3.646B	$3.797B
Total Assets	$3.800B	$3.958B
YoY Change	-5.65%	-1.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$142.4M	$109.7M
YoY Change	5.96%	-22.28%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$148.4M	$116.9M
YoY Change	5.53%	-21.29%
LONG-TERM LIABILITIES
Long-Term Debt	$2.308B	$2.579B
YoY Change	-9.07%	3.8%
Other Long-Term Liabilities	$13.88M	$11.42M
YoY Change	7.47%	-18.88%
Total Long-Term Liabilities	$2.322B	$2.591B
YoY Change	-8.99%	3.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$148.4M	$116.9M
Total Long-Term Liabilities	$2.322B	$2.591B
Total Liabilities	$2.470B	$2.708B
YoY Change	-8.23%	2.27%
SHAREHOLDERS EQUITY
Retained Earnings	$171.2M	$94.99M
YoY Change	9.08%	-43.85%
Common Stock	$2.626B	$2.622B
YoY Change	0.18%	0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.330B	$1.250B
YoY Change
Total Liabilities & Shareholders Equity	$3.800B	$3.958B
YoY Change	-5.65%	-1.22%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$76.17M	-$5.184M
YoY Change	-722.21%	1062.33%
Depreciation, Depletion And Amortization	$47.77M	$29.70M
YoY Change	-3.46%	19.05%
Cash From Operating Activities	$31.87M	$26.63M
YoY Change	-12.28%	-48.69%
INVESTING ACTIVITIES
Capital Expenditures	$16.97M	$40.03M
YoY Change	-76.45%	-39.95%
Acquisitions
YoY Change
Other Investing Activities	$50.00K	$35.67M
YoY Change	-99.15%	1152.09%
Cash From Investing Activities	-$16.92M	-$4.362M
YoY Change	-74.42%	-93.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-24.67M	-$4.878M
YoY Change	-176.38%	-121.2%
NET CHANGE
Cash From Operating Activities	31.87M	$26.63M
Cash From Investing Activities	-16.92M	-$4.362M
Cash From Financing Activities	-24.67M	-$4.878M
Net Change In Cash	-9.719M	$17.39M
YoY Change	-492.21%	56.76%
FREE CASH FLOW
Cash From Operating Activities	$31.87M	$26.63M
Capital Expenditures	$16.97M	$40.03M
Free Cash Flow	$14.90M	-$13.40M
YoY Change	-141.69%	-9.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48755415	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48755415	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-446000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	29699000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	15709000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	15333000	usd
CY2024Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	8151000	usd
CY2023Q1	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	7260000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	27327000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	26057000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50341000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51692000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	233000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3218000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5644000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5925000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	107405000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	109485000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-2384000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	2548000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1357000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	164000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3444000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2205000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	35476000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	25231000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-425000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4898000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	418000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-230000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-834000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-5184000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-446000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48466000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48466000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48336000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48336000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1255679000	usd
CY2024Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	362000	usd
CY2024Q1	opi	Shares Granted Value Share Based Payment Arrangement Forfeited And Repurchased SharesGrantedValueShareBasedPaymentArrangementForfeitedAndRepurchased	6000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	24947000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3444000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-5184000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	487000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1250364000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1386335000	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	477000	usd
CY2023Q1	opi	Shares Granted Value Share Based Payment Arrangement Forfeited And Repurchased SharesGrantedValueShareBasedPaymentArrangementForfeitedAndRepurchased	15000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-446000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	26710000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1359641000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-5184000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2205000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17669000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24614000	usd
CY2024Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	3408000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	2365000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	-2384000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	2548000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-425000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	7379000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	4173000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-90000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-204000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-230000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-834000	usd
CY2024Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-2934000	usd
CY2023Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-2846000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	3342000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	2841000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	773000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1189000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-17207000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4110000	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	234000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	972000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26632000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51900000	usd
CY2024Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	40034000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	66665000	usd
CY2024Q1	opi	Contributions To Unconsolidated Joint Ventures ContributionsToUnconsolidatedJointVentures	0	usd
CY2023Q1	opi	Contributions To Unconsolidated Joint Ventures ContributionsToUnconsolidatedJointVentures	2263000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	35672000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	5112000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4362000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63816000	usd
CY2024Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	350000000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	280500000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	232000000	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	75000000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	247000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	25000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	100000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	19885000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	266000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	487000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26710000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4878000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23011000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17392000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11095000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26714000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12249000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44106000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23344000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	34639000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	25033000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	18084000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	41172000	usd
CY2024Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	969000	usd
CY2023Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	2106000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23513000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23344000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	20593000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44106000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23344000	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	3000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	126000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5187000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-572000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48466000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48466000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48336000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48336000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2024Q1	opi	Number Of Operating Lease Executed NumberOfOperatingLeaseExecuted	13	lease
CY2024Q1	opi	Operating Leases Committed Expenditures On Leases Executed In Period Area Of Leased Property OperatingLeasesCommittedExpendituresOnLeasesExecutedInPeriodAreaOfLeasedProperty	488000	sqft
CY2024Q1	opi	Operating Leases Weighted Average Lease Term OperatingLeasesWeightedAverageLeaseTerm	P9Y3M18D
CY2024Q1	opi	Operating Leases Committed Expenditures On Leases Executed In Period OperatingLeasesCommittedExpendituresOnLeasesExecutedInPeriod	10977000	usd
CY2024Q1	opi	Operating Leases Committed Expenditures On Leases Executed In Period Committed But Unspent Tenant Related Obligations OperatingLeasesCommittedExpendituresOnLeasesExecutedInPeriodCommittedButUnspentTenantRelatedObligations	103390000	usd
CY2024Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2024Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2024Q1	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases provide for base rent payments and, in addition, may include variable payments. Rental income from operating leases, including any payments derived by index or market-based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term. Allowances for bad debts are recognized as a direct reduction of rental income. In certain circumstances, some leases provide the tenant with the right to terminate if the legislature or other funding authority does not appropriate the funding necessary for the tenant to meet its lease obligations; we have determined the fixed non-cancelable lease term of these leases to </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be the full term of the lease because we believe the occurrence of early terminations to be a remote contingency based on both our historical experience and our assessments of the likelihood of lease cancellation on a separate lease basis.</span></div>
CY2024Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	7379000	usd
CY2023Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	4173000	usd
CY2024Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	119102000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	112440000	usd
CY2024Q1	us-gaap	Variable Lease Income VariableLeaseIncome	22558000	usd
CY2023Q1	us-gaap	Variable Lease Income VariableLeaseIncome	21370000	usd
CY2024Q1	opi	Tenant Reimbursement Income TenantReimbursementIncome	21329000	usd
CY2023Q1	opi	Tenant Reimbursement Income TenantReimbursementIncome	20066000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-425000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	869	shares
CY2024Q1	opi	Stock Repurchased During Period Price Per Share StockRepurchasedDuringPeriodPricePerShare	7.12
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	487000	usd
CY2024Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture
CY2024Q1	opi	Number Of Joint Ventures NumberOfJointVentures	2	joint_venture

Files In Submission

Name	View Source	Status
0001456772-24-000035-index-headers.html	Edgar Link	pending
0001456772-24-000035-index.html	Edgar Link	pending
0001456772-24-000035.txt	Edgar Link	pending
0001456772-24-000035-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opi-20240331.htm	Edgar Link	pending
opi-20240331.xsd	Edgar Link	pending
opi_33124x10qex311.htm	Edgar Link	pending
opi_33124x10qex312.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
opi-20240331_cal.xml	Edgar Link	unprocessable
opi-20240331_def.xml	Edgar Link	unprocessable
opi-20240331_lab.xml	Edgar Link	unprocessable
opi-20240331_pre.xml	Edgar Link	unprocessable
opi-20240331_htm.xml	Edgar Link	completed
opi_33124x10qex313.htm	Edgar Link	pending
opi_33124x10qex314.htm	Edgar Link	pending
opi_33124x10qex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPI
OFFICE PROPERTIES INCOME TRUST Stock $opi

2024 Q2 Form 10-Q Financial Statement

#000145677224000035 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPI OFFICE PROPERTIES INCOME TRUST Stock $opi

2024 Q2 Form 10-Q Financial Statement

#000145677224000035 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPI
OFFICE PROPERTIES INCOME TRUST Stock $opi